GK444 is an HDAC1/2 inhibitor (IC50: 100 and 92 nM for HDAC1 and HDAC2, respectively); it inhibits Caco-2 cells with an IC50 of 4.1 μM; it reduces TGF-β1-induced COL1A1 mRNA levels in primary normal human lung fibroblasts; it attenuates bleomycin-induced pulmonary fibrosis in mice.